Literature DB >> 8754827

The human clotting factor VIII cDNA contains an autonomously replicating sequence consensus- and matrix attachment region-like sequence that binds a nuclear factor, represses heterologous gene expression, and mediates the transcriptional effects of sodium butyrate.

F J Fallaux1, R C Hoeben, S J Cramer, D J van den Wollenberg, E Briët, H van Ormondt, A J van Der Eb.   

Abstract

Expression of the human blood-clotting factor VIII (FVIII) cDNA is hampered by the presence of sequences located in the coding region that repress transcription. We have previously identified a 305-bp fragment within the FVIII cDNA that is involved in the repression (R.C. Hoeben, F.J. Fallaux, S.J. Cramer, D.J.M. van den Wollenberg, H. van Ormondt, E. Briet, and A.J. van der Eb, Blood 85:2447-2454, 1995). Here, we show that this 305-bp region of FVIII cDNA contains sequences that resemble the yeast (Saccharomyces cerevisiae) autonomously replicating sequence consensus. Two of these DNA elements coincide with AT-rich sequences that are often found in matrix attachment regions or scaffold-attached regions. One of these elements, consisting of nucleotides 1569 to 1600 of the FVIII cDNA (nucleotide numbering is according to the system of Wood et al. (W.I. Wood, D.J. Capon, C.C. Simonsen, D.L. Eaton, J. Gitschier, D. Keyt, P.H. Seeburg, D.H. Smith, P. Hollingshead, K.L. Wion, et al., Nature [London] 312:330-337,1984), binds a nuclear factor in vitro but loses this capacity after four of its base pairs have been changed. A synthetic heptamer of this segment can repress the expression of a chloramphenicol acetyltransferase (CAT) reporter gene and also loses this capacity upon mutation. Furthermore, we demonstrate that repression by FVIII sequences can be relieved by sodium butyrate. We demonstrate that the synthetic heptamer (FVIII nucleotides 1569 to 1600), when placed upstream of the Moloney murine leukemia virus long terminal repeat promoter that drives the CAT reporter, can render the CAT reporter inducible by butyrate. This effect was absent when the same element was mutated. The stimulatory effect of butyrate could not be attributed to butyrate-responsive elements in the studied long terminal repeat promoters. Our data provide a functional characterization of the sequences that repress expression of the FVIII cDNA. These data also suggest a link between transcriptional repression by FVIII cDNA elements and the stimulatory effect of butyrate on FVIII cDNA expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8754827      PMCID: PMC231425          DOI: 10.1128/MCB.16.8.4264

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

Review 1.  Ras C-terminal processing enzymes--new drug targets?

Authors:  J B Gibbs
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

2.  Expression of functional factor VIII in primary human skin fibroblasts after retrovirus-mediated gene transfer.

Authors:  R C Hoeben; R C van der Jagt; F Schoute; N H van Tilburg; M P Verbeet; E Briët; H van Ormondt; A J van der Eb
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

3.  Sequence-specific antirepression of histone H1-mediated inhibition of basal RNA polymerase II transcription.

Authors:  G E Croston; L A Kerrigan; L M Lira; D R Marshak; J T Kadonaga
Journal:  Science       Date:  1991-02-08       Impact factor: 47.728

Review 4.  Hemophilia treatment in historical perspective: a review of medical and social developments.

Authors:  F R Rosendaal; C Smit; E Briët
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

Review 5.  Gene transfer as an approach to cure patients with hemophilia A or B.

Authors:  A R Thompson; T D Palmer; C M Lynch; A D Miller
Journal:  Curr Stud Hematol Blood Transfus       Date:  1991

6.  Mutational analysis of the consensus sequence of a replication origin from yeast chromosome III.

Authors:  J V Van Houten; C S Newlon
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

7.  Protein dissociation from GRP78 and secretion are blocked by depletion of cellular ATP levels.

Authors:  A J Dorner; L C Wasley; R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

8.  Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position.

Authors:  R C Hoeben; A A Migchielsen; R C van der Jagt; H van Ormondt; A J van der Eb
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

9.  Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene.

Authors:  E G Tuddenham; D N Cooper; J Gitschier; M Higuchi; L W Hoyer; A Yoshioka; I R Peake; R Schwaab; K Olek; H H Kazazian
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

10.  N-myc disrupts protein kinase C-mediated signal transduction in neuroblastoma.

Authors:  R Bernards
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

View more
  10 in total

1.  Expression of human blood clotting factor VIII in the mammary gland of transgenic sheep.

Authors:  H Niemann; R Halter; J W Carnwath; D Herrmann; E Lemme; D Paul
Journal:  Transgenic Res       Date:  1999-06       Impact factor: 2.788

2.  Intracellular trafficking of factor VIII to von Willebrand factor storage granules.

Authors:  J B Rosenberg; P A Foster; R J Kaufman; E A Vokac; M Moussalli; P A Kroner; R R Montgomery
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

3.  Prospects for the use of artificial chromosomes and minichromosome-like episomes in gene therapy.

Authors:  Sara Pérez-Luz; Javier Díaz-Nido
Journal:  J Biomed Biotechnol       Date:  2010-08-24

4.  Temporal and spatial expression of biologically active human factor VIII in the milk of transgenic mice driven by mammary-specific bovine alpha-lactalbumin regulation sequences.

Authors:  Chuan-Mu Chen; Chih-Hong Wang; Shinn-Chih Wu; Chih-Cheng Lin; Shwu-Hwa Lin; Winston T K Cheng
Journal:  Transgenic Res       Date:  2002-06       Impact factor: 2.788

5.  Generation of an optimized lentiviral vector encoding a high-expression factor VIII transgene for gene therapy of hemophilia A.

Authors:  J M Johnston; G Denning; C B Doering; H T Spencer
Journal:  Gene Ther       Date:  2012-09-20       Impact factor: 5.250

6.  Kaposi's Sarcoma-Associated Herpesvirus Genome Replication, Partitioning, and Maintenance in Latency.

Authors:  Eriko Ohsaki; Keiji Ueda
Journal:  Front Microbiol       Date:  2012-01-24       Impact factor: 5.640

7.  Stable high-level expression of factor VIII in Chinese hamster ovary cells in improved elongation factor-1 alpha-based system.

Authors:  Nadezhda A Orlova; Sergey V Kovnir; Alexandre G Gabibov; Ivan I Vorobiev
Journal:  BMC Biotechnol       Date:  2017-03-24       Impact factor: 2.563

8.  Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCs.

Authors:  Jin Jea Sung; Chul-Yong Park; Joong Woo Leem; Myung Soo Cho; Dong-Wook Kim
Journal:  Exp Mol Med       Date:  2019-04-17       Impact factor: 8.718

9.  Defining the Optimal FVIII Transgene for Placental Cell-Based Gene Therapy to Treat Hemophilia A.

Authors:  Nadia El-Akabawy; Martin Rodriguez; Ritu Ramamurthy; Andrew Rabah; Brady Trevisan; Alshaimaa Morsi; Sunil George; Jordan Shields; Diane Meares; Andrew Farland; Anthony Atala; Christopher B Doering; H Trent Spencer; Christopher D Porada; Graça Almeida-Porada
Journal:  Mol Ther Methods Clin Dev       Date:  2020-03-14       Impact factor: 6.698

10.  Blood Clotting Factor VIII: From Evolution to Therapy.

Authors:  N A Orlova; S V Kovnir; I I Vorobiev; A G Gabibov; A I Vorobiev
Journal:  Acta Naturae       Date:  2013-04       Impact factor: 1.845

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.